We are live on ! Find out more
RNAM

Avidity Biosciences

Delisted

RNAM was delisted on the 26th of February, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$115M -$1.52M -102,410 -1%
RI
2
RTW Investments
New York
$69.7M
BlackRock
3
BlackRock
New York
$57.1M +$9.9M +665,653 +20%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$55.3M -$26.7K -1,792 -0%
EC
5
EcoR1 Capital
California
$40.1M
Federated Hermes
6
Federated Hermes
Pennsylvania
$36M
Vanguard Group
7
Vanguard Group
Pennsylvania
$35.2M +$1.84M +123,759 +5%
CAC
8
Cowen and Company
New York
$32.9M +$33.7M +2,264,150 New
RCM
9
RA Capital Management
Massachusetts
$31.5M
APM
10
Avidity Partners Management
Texas
$30.2M +$524K +35,200 +2%
CAM
11
Cormorant Asset Management
Massachusetts
$29.2M
State Street
12
State Street
Massachusetts
$26.7M +$2.91M +195,808 +12%
ACA
13
Avoro Capital Advisors
New York
$18.9M
BC
14
Boxer Capital
California
$16.3M
Wellington Management Group
15
Wellington Management Group
Massachusetts
$15.5M -$1M -67,521 -6%
Alkeon Capital Management
16
Alkeon Capital Management
New York
$12.4M
Geode Capital Management
17
Geode Capital Management
Massachusetts
$12.3M +$1.66M +111,605 +15%
ACM
18
Alethea Capital Management
Washington
$12.1M -$811K -54,484 -6%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$7.41M +$2.05M +137,519 +37%
GPP
20
Great Point Partners
Connecticut
$7.26M
Northern Trust
21
Northern Trust
Illinois
$6.64M +$1.24M +83,520 +22%
Artisan Partners
22
Artisan Partners
Wisconsin
$5.71M +$5.85M +393,341 New
5VM
23
5AM Venture Management
California
$5.67M
Charles Schwab
24
Charles Schwab
California
$4.9M +$561K +37,677 +13%
OCA
25
Octagon Capital Advisors
New York
$4.67M